Required to reconstitute lyophilized peptides before use in research.
PEPTIDE BLEND
Synergistic compounds
AMINO ACIDS
BPC-157 sequence
STUDIES
Combined research
PURITY
HPLC verified
Key findings from published peer-reviewed research studies.
Synergistic Peptides
Combined Studies
Optimal Blend Ratio
Toxic Effects Found
Combined BPC-157/TB-500 showed enhanced healing outcomes versus either peptide alone
Preclinical research demonstrated that the combination leverages complementary mechanisms—BPC-157’s cytoprotective properties with TB-500’s pro-angiogenic effects—resulting in accelerated tissue recovery.
Accelerated healing of tendon injuries in preclinical models
BPC-157 promoted tendon-to-bone healing while TB-500 enhanced cellular migration to injury sites, together providing a comprehensive repair response in connective tissue models.
BPC-157 demonstrated significant gastroprotective effects
Derived from human gastric juice, BPC-157 showed protective and healing effects on various GI injury models, including ulcers, fistulas, and inflammatory bowel conditions.
Dual peptide blend showed enhanced anti-inflammatory response
The combination modulated multiple inflammatory pathways including NO system, prostaglandins, and dopaminergic system, providing broader anti-inflammatory coverage.
Toxic Effects
Blend Compatibility
Reconstituted Stability
Preclinical studies show a very wide therapeutic index with no reported toxic effects even at high doses. LD50 has not been reached in animal studies.
Well-tolerated in preclinical models with no significant organ toxicity or adverse hematological effects observed.
No adverse interactions between BPC-157 and TB-500 have been reported. The 1:1 blend ratio is the most commonly studied combination.
Lyophilized blend is stable for 24+ months at -20°C. Reconstituted solution should be used within 21 days when stored at 2-8°C.
For research use only. Individual peptide dosing protocols should be followed when designing combination studies.
Disclaimer: This product is intended for research use only. Not for human consumption, therapeutic use, or diagnostic purposes.
~6,420 Da
1:1 Ratio
≥99% each
<0.1 EU/mg
| Blend Components | BPC-157 + TB-500 (1:1 ratio) |
| BPC-157 CAS | 137525-51-0 |
| TB-500 CAS | 77591-33-4 |
| BPC-157 Sequence | 15 amino acids (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) |
| TB-500 Length | 43 amino acids |
| Combined MW | ~6,420 g/mol |
| Appearance | White lyophilized powder |
| Solubility | Soluble in sterile water, bacteriostatic water |
| Purity | ≥99% each component (HPLC) |
| Endotoxin Level | <0.1 EU/mg |
These peptides work through complementary mechanisms. BPC-157 is primarily cytoprotective and promotes nitric oxide-mediated healing, while TB-500 promotes angiogenesis and cell migration. Together, they provide a more comprehensive regenerative research tool.
Our BPC-157/TB-500 blend uses a 1:1 ratio by weight, which is the most commonly cited combination in published research protocols.
Yes. We also offer TB-500 as a standalone product. The blend is designed for researchers who want the convenience of a pre-mixed formulation for combination studies.
Reconstitute with bacteriostatic water by gently adding solvent to the vial. Allow to dissolve completely without shaking. Store reconstituted solution at 2-8°C.
Each component is individually synthesized and tested via HPLC before blending. The final product undergoes additional purity, identity, endotoxin, and sterility testing.
Peer-reviewed publications and reference materials.
Sikiric P, Rucman R, et al.
Current Pharmaceutical Design (2018)
Goldstein AL, Kleinman HK
Expert Opinion on Biological Therapy (2015)
Our products are strictly intended for laboratory research use only. Not for human or animal consumption. By purchasing, you confirm that you are a licensed researcher or purchasing for research purposes.